

| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 1,864.80 | 1,787.10 | 2,028.44 | 1,947.61 | 1,725.42 |
| Total Expenses | 1,741 | 1,691.60 | 1,923.08 | 1,729.05 | 1,518.99 |
| Profit Before Tax | 123.80 | 95.50 | 105.36 | 218.56 | 206.43 |
| Profit After Tax | 90.80 | 69.60 | 78.38 | 160.50 | 133.14 |
| Operating Profit After Depreciation | 199 | 151.90 | 153.47 | 249.78 | 242.62 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 1,364.50 | 1,070.60 | 958.39 | 889.07 | 721.40 |
| Total Non Current Assets | 1,533.50 | 1,520.50 | 1,446.46 | 1,248.83 | 1,034.62 |
| Total Current Assets | 995.40 | 966.60 | 939.02 | 964.28 | 878.60 |
| Total Assets | 2,528.90 | 2,487.10 | 2,385.48 | 2,213.11 | 1,913.22 |
| Total Shareholder's Fund | 1,262.30 | 1,187.70 | 1,133.47 | 1,067.98 | 933.40 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 280.40 | 186.72 | 315.31 | 293.73 | 229.02 |
| Net Cash Used In Investing Activities | -136.50 | -173.75 | -292.34 | -284.37 | -156.20 |
| Net Cash Used In Financing Activities | -143.60 | -27 | -7.68 | -5.56 | -96.87 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 1,864.80 | 1,787.10 | 2,028.44 | 1,947.61 | 1,725.42 |
| Total Expenses | 1,740.90 | 1,691.70 | 1,923.08 | 1,729.04 | 1,518.99 |
| Profit Before Tax | 123.90 | 95.40 | 105.36 | 218.57 | 206.43 |
| Profit After Tax | 90.90 | 69.50 | 78.38 | 160.51 | 133.14 |
| Operating Profit After Depreciation | 199.10 | 151.80 | 153.46 | 249.79 | 242.62 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 1,364.50 | 1,070.60 | 958.39 | 889.07 | 721.40 |
| Total Non Current Assets | 1,532.20 | 1,520.50 | 1,446.47 | 1,248.84 | 1,034.63 |
| Total Current Assets | 996.90 | 966.50 | 939 | 964.28 | 878.60 |
| Total Assets | 2,529.10 | 2,487 | 2,385.48 | 2,213.12 | 1,913.23 |
| Total Shareholder's Fund | 1,262.20 | 1,187.60 | 1,133.49 | 1,068.01 | 933.42 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 280.40 | 186.60 | 315.29 | 293.73 | 229.02 |
| Net Cash Used In Investing Activities | -136.50 | -173.70 | -292.34 | -284.37 | -156.20 |
| Net Cash Used In Financing Activities | -143.60 | -27 | -7.68 | -5.56 | -96.87 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 519.40 | 494.30 | 318.50 | 380.40 | 552.40 |
| Total Expenses | 414 | 411.60 | 311.30 | 355.30 | 429 |
| Profit Before Tax | 8.30 | -9.20 | -47 | -30.40 | 68.30 |
| Profit After Tax | 14.40 | -5.90 | -34.90 | -22.40 | 50.20 |
| Operating Profit after Depreciation | 112 | 85.50 | 9.10 | 26.10 | 123.90 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 519.40 | 494.30 | 318.50 | 380.40 | 552.40 |
| Total Expenses | 413.80 | 411.60 | 311.10 | 355.60 | 428.90 |
| Profit Before Tax | 8.50 | -9.20 | -46.80 | -30.70 | 68.40 |
| Profit After Tax | 14.60 | -5.90 | -34.70 | -22.70 | 50.30 |
| Operating Profit after Depreciation | 112.20 | 85.50 | 9.30 | 25.80 | 124 |
₹0.2/Share
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,794.30 | ₹4,30,512.67 |
| Divis Laboratories Ltd | ₹6,651.25 | ₹1,76,569.79 |
| Torrent Pharmaceuticals Ltd | ₹4,570 | ₹1,54,669.57 |
| Cipla Ltd | ₹1,383 | ₹1,11,725.01 |
| Zydus Lifesciences Ltd | ₹1,105.65 | ₹1,11,254.26 |
| Fund Name | AUM |
|---|---|
| ICICI Pru P.H.D Fund | 1.21% |
| Tata Small Cap Fund | 0.55% |
| Bandhan BSE Healthcare Index Fund | 0.05% |
| Motilal Oswal BSE 1000 Index Fund | 0% |
Hikal slumped 7.96% to Rs 202.85 after its consolidated net profit tanked 71.33% to Rs 14.39 crore in Q4 F2Y6 as against Rs 50.2 crore in Q4 FY25.
29 May 2026, 09:49 am
Of Rs 0.4 per share
28 May 2026, 11:52 am
Hikal's consolidated net profit tanked 71.33% to Rs 14.39 crore in Q4 F2Y6 as against Rs 50.2 crore in Q4 FY25.
28 May 2026, 08:38 am
On 27 May 2026
21 May 2026, 03:28 pm
Of Rs 0.2 per share
11 Feb 2026, 05:07 pm

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.